A senior Massey University public health researcher says the medicinal cannabis scheme in New Zealand has transformed dramatically since it was implemented in 2020.
Marta Rychert said the supply of such products had increased 14 times compared with four years ago.
In addition, most prescriptions were now for high-potency, dried cannabis flowers rather than oils or oral liquids, and prices were now comparable to the black market.
In the study, Rychert and co-author Chris Wilkins wrote private cannabis clinics had improved access and care for patients needing medicinal marijuana, but they raised concerns about the commercial imperative for those clinics to sell only one product, regardless of patient need.
Read more at RNZ News.